Alogliptin
Active substance: alogliptin benzoate
TABLET, FILM COATED · ALOGLIPTIN BENZOATE 25 mg/1
United StatesActive
Marketing holder: Padagis Israel Pharmaceuticals Ltd
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
- ALOGLIPTIN BENZOATE · 25 mg/1
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| EU 1 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208e-4a51-70f7-aec8-5f5594020a03,01a1208e-f60f-7a9f-81f0-6659f5df1c9a,01a12090-67d5-7dca-bd90-a0d6a5c321d5,01a12093-8a9a-7e90-96e2-0da74eefaa59,01a12095-0d41-7a3a-a8bc-f10c0f6bf97c;count=10 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 45802-150
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 45802-150 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 45802-150 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 45802-150 · Verified 2026-10-09 · open in source